ID   C19L2_HUMAN             Reviewed;         894 AA.
AC   Q2TBE0; A4FU66; A4FU67; A4FU68; A8KAD6; Q6PHW1; Q96MI1;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 4.
DT   07-APR-2021, entry version 127.
DE   RecName: Full=CWF19-like protein 2;
GN   Name=CWF19L2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 13-894 (ISOFORM 1).
RC   TISSUE=Prostate, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 119-894 (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 120-894 (ISOFORMS 2 AND 3), AND VARIANTS
RP   TYR-443 AND CYS-894.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-479, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-479, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-360; SER-372 AND
RP   SER-479, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-604, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-171 AND LYS-604, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- INTERACTION:
CC       Q2TBE0; O94929-2: ABLIM3; NbExp=3; IntAct=EBI-5453285, EBI-11961672;
CC       Q2TBE0; Q9UBB4: ATXN10; NbExp=3; IntAct=EBI-5453285, EBI-702390;
CC       Q2TBE0; Q9Y2T1: AXIN2; NbExp=3; IntAct=EBI-5453285, EBI-4400025;
CC       Q2TBE0; Q9BYV9: BACH2; NbExp=3; IntAct=EBI-5453285, EBI-1642333;
CC       Q2TBE0; Q9P1Z2: CALCOCO1; NbExp=6; IntAct=EBI-5453285, EBI-749920;
CC       Q2TBE0; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-5453285, EBI-739580;
CC       Q2TBE0; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-5453285, EBI-3866279;
CC       Q2TBE0; Q9H257: CARD9; NbExp=3; IntAct=EBI-5453285, EBI-751319;
CC       Q2TBE0; Q9H257-2: CARD9; NbExp=3; IntAct=EBI-5453285, EBI-11530605;
CC       Q2TBE0; Q68D86: CCDC102B; NbExp=3; IntAct=EBI-5453285, EBI-10171570;
CC       Q2TBE0; Q96JN2-2: CCDC136; NbExp=3; IntAct=EBI-5453285, EBI-10171416;
CC       Q2TBE0; Q2TAC2: CCDC57; NbExp=3; IntAct=EBI-5453285, EBI-2808286;
CC       Q2TBE0; A6NC98: CCDC88B; NbExp=3; IntAct=EBI-5453285, EBI-347573;
CC       Q2TBE0; Q96MT8-3: CEP63; NbExp=3; IntAct=EBI-5453285, EBI-11522539;
CC       Q2TBE0; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-5453285, EBI-739624;
CC       Q2TBE0; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-5453285, EBI-742887;
CC       Q2TBE0; Q96M91: CFAP53; NbExp=3; IntAct=EBI-5453285, EBI-742422;
CC       Q2TBE0; Q8N137: CNTROB; NbExp=3; IntAct=EBI-5453285, EBI-947360;
CC       Q2TBE0; Q69YN2: CWF19L1; NbExp=3; IntAct=EBI-5453285, EBI-719164;
CC       Q2TBE0; P17661: DES; NbExp=3; IntAct=EBI-5453285, EBI-1055572;
CC       Q2TBE0; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-5453285, EBI-11988027;
CC       Q2TBE0; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-5453285, EBI-742102;
CC       Q2TBE0; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-5453285, EBI-10175124;
CC       Q2TBE0; A0A0C3SFZ9: FCHO1; NbExp=3; IntAct=EBI-5453285, EBI-11977403;
CC       Q2TBE0; A1L4K1: FSD2; NbExp=3; IntAct=EBI-5453285, EBI-5661036;
CC       Q2TBE0; P51114-2: FXR1; NbExp=3; IntAct=EBI-5453285, EBI-11022345;
CC       Q2TBE0; P51116: FXR2; NbExp=3; IntAct=EBI-5453285, EBI-740459;
CC       Q2TBE0; O95995: GAS8; NbExp=3; IntAct=EBI-5453285, EBI-1052570;
CC       Q2TBE0; P14136: GFAP; NbExp=6; IntAct=EBI-5453285, EBI-744302;
CC       Q2TBE0; Q08379: GOLGA2; NbExp=3; IntAct=EBI-5453285, EBI-618309;
CC       Q2TBE0; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-5453285, EBI-5916454;
CC       Q2TBE0; Q4V328: GRIPAP1; NbExp=3; IntAct=EBI-5453285, EBI-717919;
CC       Q2TBE0; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-5453285, EBI-748420;
CC       Q2TBE0; Q9UJC3: HOOK1; NbExp=3; IntAct=EBI-5453285, EBI-746704;
CC       Q2TBE0; Q96ED9: HOOK2; NbExp=3; IntAct=EBI-5453285, EBI-743290;
CC       Q2TBE0; Q96ED9-2: HOOK2; NbExp=3; IntAct=EBI-5453285, EBI-10961706;
CC       Q2TBE0; O75031: HSF2BP; NbExp=3; IntAct=EBI-5453285, EBI-7116203;
CC       Q2TBE0; Q9Y6K9: IKBKG; NbExp=3; IntAct=EBI-5453285, EBI-81279;
CC       Q2TBE0; Q13422-7: IKZF1; NbExp=3; IntAct=EBI-5453285, EBI-11522367;
CC       Q2TBE0; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-5453285, EBI-1055254;
CC       Q2TBE0; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-5453285, EBI-2556193;
CC       Q2TBE0; Q8N6L0: KASH5; NbExp=3; IntAct=EBI-5453285, EBI-749265;
CC       Q2TBE0; Q5T7B8-2: KIF24; NbExp=3; IntAct=EBI-5453285, EBI-10213781;
CC       Q2TBE0; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-5453285, EBI-14069005;
CC       Q2TBE0; Q6A162: KRT40; NbExp=3; IntAct=EBI-5453285, EBI-10171697;
CC       Q2TBE0; Q9UBR4-2: LHX3; NbExp=3; IntAct=EBI-5453285, EBI-12039345;
CC       Q2TBE0; Q9NQ69: LHX9; NbExp=3; IntAct=EBI-5453285, EBI-10175218;
CC       Q2TBE0; P48059-3: LIMS1; NbExp=3; IntAct=EBI-5453285, EBI-12864460;
CC       Q2TBE0; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-5453285, EBI-1216080;
CC       Q2TBE0; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-5453285, EBI-741037;
CC       Q2TBE0; Q8TC57: M1AP; NbExp=3; IntAct=EBI-5453285, EBI-748182;
CC       Q2TBE0; Q9Y6D9: MAD1L1; NbExp=6; IntAct=EBI-5453285, EBI-742610;
CC       Q2TBE0; P50221: MEOX1; NbExp=6; IntAct=EBI-5453285, EBI-2864512;
CC       Q2TBE0; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-5453285, EBI-742948;
CC       Q2TBE0; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-5453285, EBI-11522433;
CC       Q2TBE0; Q15742: NAB2; NbExp=6; IntAct=EBI-5453285, EBI-8641936;
CC       Q2TBE0; Q9GZM8: NDEL1; NbExp=3; IntAct=EBI-5453285, EBI-928842;
CC       Q2TBE0; Q5VU43-2: PDE4DIP; NbExp=3; IntAct=EBI-5453285, EBI-9640281;
CC       Q2TBE0; Q4G0R1: PIBF1; NbExp=3; IntAct=EBI-5453285, EBI-14066006;
CC       Q2TBE0; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-5453285, EBI-79165;
CC       Q2TBE0; O43586: PSTPIP1; NbExp=3; IntAct=EBI-5453285, EBI-1050964;
CC       Q2TBE0; Q6NUQ1: RINT1; NbExp=6; IntAct=EBI-5453285, EBI-726876;
CC       Q2TBE0; Q15427: SF3B4; NbExp=6; IntAct=EBI-5453285, EBI-348469;
CC       Q2TBE0; Q13573: SNW1; NbExp=3; IntAct=EBI-5453285, EBI-632715;
CC       Q2TBE0; O75558: STX11; NbExp=3; IntAct=EBI-5453285, EBI-714135;
CC       Q2TBE0; Q86VP1: TAX1BP1; NbExp=3; IntAct=EBI-5453285, EBI-529518;
CC       Q2TBE0; Q86TI0: TBC1D1; NbExp=3; IntAct=EBI-5453285, EBI-1644036;
CC       Q2TBE0; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-5453285, EBI-1105213;
CC       Q2TBE0; Q13625-3: TP53BP2; NbExp=3; IntAct=EBI-5453285, EBI-10175039;
CC       Q2TBE0; Q12933: TRAF2; NbExp=3; IntAct=EBI-5453285, EBI-355744;
CC       Q2TBE0; P36406: TRIM23; NbExp=3; IntAct=EBI-5453285, EBI-740098;
CC       Q2TBE0; P14373: TRIM27; NbExp=6; IntAct=EBI-5453285, EBI-719493;
CC       Q2TBE0; O94972: TRIM37; NbExp=6; IntAct=EBI-5453285, EBI-741602;
CC       Q2TBE0; Q9BYV2: TRIM54; NbExp=6; IntAct=EBI-5453285, EBI-2130429;
CC       Q2TBE0; Q9C026: TRIM9; NbExp=6; IntAct=EBI-5453285, EBI-720828;
CC       Q2TBE0; P08670: VIM; NbExp=3; IntAct=EBI-5453285, EBI-353844;
CC       Q2TBE0; Q8N1B4: VPS52; NbExp=3; IntAct=EBI-5453285, EBI-2799833;
CC       Q2TBE0; Q96BR9: ZBTB8A; NbExp=3; IntAct=EBI-5453285, EBI-742740;
CC       Q2TBE0; Q9H0C1: ZMYND12; NbExp=3; IntAct=EBI-5453285, EBI-12030590;
CC       Q2TBE0; P13682: ZNF35; NbExp=3; IntAct=EBI-5453285, EBI-11041653;
CC       Q2TBE0; Q8N720: ZNF655; NbExp=3; IntAct=EBI-5453285, EBI-625509;
CC       Q2TBE0; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-5453285, EBI-527853;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q2TBE0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2TBE0-2; Sequence=VSP_030592, VSP_030593;
CC       Name=3;
CC         IsoId=Q2TBE0-3; Sequence=VSP_030590, VSP_030591;
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the CWF19 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI10440.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI10441.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI10441.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAI10442.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI10443.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI18670.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB71307.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAF85690.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP000766; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001823; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK056905; BAB71307.1; ALT_INIT; mRNA.
DR   EMBL; AK293001; BAF85690.1; ALT_SEQ; mRNA.
DR   EMBL; BC056241; AAH56241.1; -; mRNA.
DR   EMBL; BC110439; AAI10440.1; ALT_INIT; mRNA.
DR   EMBL; BC110440; AAI10441.1; ALT_SEQ; mRNA.
DR   EMBL; BC110441; AAI10442.1; ALT_INIT; mRNA.
DR   EMBL; BC110442; AAI10443.2; ALT_INIT; mRNA.
DR   EMBL; BC118669; AAI18670.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8336.2; -. [Q2TBE0-1]
DR   RefSeq; NP_689647.2; NM_152434.2. [Q2TBE0-1]
DR   PDB; 6ID0; EM; 2.90 A; U=1-894.
DR   PDB; 6ID1; EM; 2.86 A; U=1-894.
DR   PDBsum; 6ID0; -.
DR   PDBsum; 6ID1; -.
DR   SMR; Q2TBE0; -.
DR   BioGRID; 126821; 118.
DR   IntAct; Q2TBE0; 104.
DR   STRING; 9606.ENSP00000282251; -.
DR   iPTMnet; Q2TBE0; -.
DR   PhosphoSitePlus; Q2TBE0; -.
DR   BioMuta; CWF19L2; -.
DR   DMDM; 300669615; -.
DR   EPD; Q2TBE0; -.
DR   jPOST; Q2TBE0; -.
DR   MassIVE; Q2TBE0; -.
DR   MaxQB; Q2TBE0; -.
DR   PaxDb; Q2TBE0; -.
DR   PeptideAtlas; Q2TBE0; -.
DR   PRIDE; Q2TBE0; -.
DR   ProteomicsDB; 61491; -. [Q2TBE0-1]
DR   ProteomicsDB; 61492; -. [Q2TBE0-2]
DR   ProteomicsDB; 61493; -. [Q2TBE0-3]
DR   Antibodypedia; 50383; 36 antibodies.
DR   Ensembl; ENST00000282251; ENSP00000282251; ENSG00000152404. [Q2TBE0-1]
DR   GeneID; 143884; -.
DR   KEGG; hsa:143884; -.
DR   UCSC; uc010rvp.3; human. [Q2TBE0-1]
DR   CTD; 143884; -.
DR   DisGeNET; 143884; -.
DR   GeneCards; CWF19L2; -.
DR   HGNC; HGNC:26508; CWF19L2.
DR   HPA; ENSG00000152404; Low tissue specificity.
DR   neXtProt; NX_Q2TBE0; -.
DR   OpenTargets; ENSG00000152404; -.
DR   PharmGKB; PA134914164; -.
DR   VEuPathDB; HostDB:ENSG00000152404.15; -.
DR   eggNOG; KOG2477; Eukaryota.
DR   GeneTree; ENSGT00940000155627; -.
DR   HOGENOM; CLU_015540_0_0_1; -.
DR   InParanoid; Q2TBE0; -.
DR   OMA; VFYEIAN; -.
DR   OrthoDB; 1407830at2759; -.
DR   PhylomeDB; Q2TBE0; -.
DR   TreeFam; TF351271; -.
DR   PathwayCommons; Q2TBE0; -.
DR   BioGRID-ORCS; 143884; 431 hits in 991 CRISPR screens.
DR   ChiTaRS; CWF19L2; human.
DR   GenomeRNAi; 143884; -.
DR   Pharos; Q2TBE0; Tdark.
DR   PRO; PR:Q2TBE0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q2TBE0; protein.
DR   Bgee; ENSG00000152404; Expressed in tendon of biceps brachii and 209 other tissues.
DR   ExpressionAtlas; Q2TBE0; baseline and differential.
DR   Genevisible; Q2TBE0; HS.
DR   GO; GO:0071014; C:post-mRNA release spliceosomal complex; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   Gene3D; 3.30.428.10; -; 1.
DR   InterPro; IPR040194; Cwf19-like.
DR   InterPro; IPR006768; Cwf19-like_C_dom-1.
DR   InterPro; IPR006767; Cwf19-like_C_dom-2.
DR   InterPro; IPR036265; HIT-like_sf.
DR   PANTHER; PTHR12072; PTHR12072; 1.
DR   Pfam; PF04677; CwfJ_C_1; 1.
DR   Pfam; PF04676; CwfJ_C_2; 1.
DR   SUPFAM; SSF54197; SSF54197; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Isopeptide bond;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..894
FT                   /note="CWF19-like protein 2"
FT                   /id="PRO_0000315648"
FT   COILED          13..107
FT                   /evidence="ECO:0000255"
FT   COILED          166..281
FT                   /evidence="ECO:0000255"
FT   COILED          502..530
FT                   /evidence="ECO:0000255"
FT   COILED          644..675
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        77..104
FT                   /note="Lys-rich"
FT   COMPBIAS        108..115
FT                   /note="Poly-Ser"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         479
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   CROSSLNK        171
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        604
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         625..672
FT                   /note="FMGKTDGDYYTLDDMFVSKAAERERLGEEEENQRKKAIAEHRSLAAQM ->
FT                   QLRENVLVKRKRTKGKKLLLSIGVLLHKWKNVCIVLTALNFPSILLLQ (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030590"
FT   VAR_SEQ         673..894
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030591"
FT   VAR_SEQ         735..742
FT                   /note="MFRKSLVK -> IKSRTVIQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030592"
FT   VAR_SEQ         743..894
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030593"
FT   VARIANT         210
FT                   /note="P -> T (in dbSNP:rs608634)"
FT                   /id="VAR_038268"
FT   VARIANT         443
FT                   /note="H -> Y (in dbSNP:rs659040)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_038269"
FT   VARIANT         445
FT                   /note="H -> Q (in dbSNP:rs35968518)"
FT                   /id="VAR_038270"
FT   VARIANT         537
FT                   /note="G -> R (in dbSNP:rs17106909)"
FT                   /id="VAR_038271"
FT   VARIANT         894
FT                   /note="Y -> C (in dbSNP:rs3758911)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_038272"
FT   CONFLICT        584
FT                   /note="E -> K (in Ref. 3; AAI10443)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        626
FT                   /note="M -> G (in Ref. 3; AAH56241)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        819
FT                   /note="P -> L (in Ref. 2; BAF85690)"
FT                   /evidence="ECO:0000305"
FT   STRAND          549..551
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          557..559
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          582..587
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   TURN            592..596
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           599..608
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           615..621
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          623..625
FT                   /evidence="ECO:0007744|PDB:6ID0"
FT   STRAND          631..634
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           637..642
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          648..650
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           651..660
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           662..673
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          676..683
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          686..688
FT                   /evidence="ECO:0007744|PDB:6ID0"
FT   STRAND          694..699
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          702..704
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          711..717
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           727..746
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          753..756
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          768..770
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           775..778
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           781..790
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          806..808
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   TURN            811..813
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          821..825
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   STRAND          828..833
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           846..853
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   TURN            858..861
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   TURN            869..875
FT                   /evidence="ECO:0007744|PDB:6ID1"
FT   HELIX           876..882
FT                   /evidence="ECO:0007744|PDB:6ID1"
SQ   SEQUENCE   894 AA;  103787 MW;  E40E8289255C57CF CRC64;
     MATSMAAASG RFESAKSIEE RKEQTRNARA EVLRQAKANF EKEERRKELK RLRGEDTWML
     PDVNERIEQF SQEHSVKKKK KKDKHSKKAK KEKKKKSKKQ KYEKNNESSD SSSSSEDEWV
     EAVPSQTPDK EKAWKVKDEK SGKDDTQIIK RDEWMTVDFM SVKTVSSSSL KAEKETMRKI
     EQEKNQALEQ SKLMERELNP YWKDGGTGLP PEDCSVSSIT KVSVVEDGGL SWLRKSYLRM
     KEQAEKQSRN FEDIVAERYG SMEIFQSKLE DAEKAASTKE DYRRERWRKP TYSDKAQNCQ
     ESRESDLVKY GNSSRDRYAT TDTAKNSNNE KFIGDEKDKR PGSLETCRRE SNPRQNQEFS
     FGNLRAKFLR PSDDEELSFH SKGRKFEPLS SSSALVAQGS LCSGFRKPTK NSEERLTSWS
     RSDGRGDKKH SNQKPSETST DEHQHVPEDP REKSQDEVLR DDPPKKEHLR DTKSTFAGSP
     ERESIHILSV DEKNKLGAKI IKAEMMGNME LAEQLKVQLE KANKFKETIT QIPKKSGVEN
     EDQQEVILVR TDQSGRVWPV NTPGKSLESQ GGRRKRQMVS THEERERVRY FHDDDNLSLN
     DLVKNEKMGT AENQNKLFMR MASKFMGKTD GDYYTLDDMF VSKAAERERL GEEEENQRKK
     AIAEHRSLAA QMEKCLYCFD SSQFPKHLIV AIGVKVYLCL PNVRSLTEGH CLIVPLQHHR
     AATLLDEDIW EEIQMFRKSL VKMFEDKGLD CIFLETNMSM KKQYHMVYEC IPLPKEVGDM
     APIYFKKAIM ESDEEWSMNK KLIDLSSKDI RKSVPRGLPY FSVDFGLHGG FAHVIEDQHK
     FPHYFGKEII GGMLDIEPRL WRKGIRESFE DQRKKALQFA QWWKPYDFTK SKNY
//
